Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

SEATTLE — Third Avenue in Seattle is slowly getting a facelift. The newest addition is overhead lights that were strung ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

Winners of the 2024 Lasker Awards include researchers who discovered and developed GLP-1 agonists, infectious disease ...

The phase 1 portion is intended to determine the safety and the optimal dose of Covigenix VAX-002 as a COVID-19 booster vaccine ... and advance safe and effective RNA or DNA vaccines and therapeutics.

The conversation around Artificial Intelligence these days appears to be mostly negative. Very few people have anything ...

Australia has a hard-earned global reputation as a ‘go to’ destination to conduct clinical trials, which is continuing to ...

CSL and Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare has granted approval for ...